KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Working Capital Changes (2016 - 2020)

Thermo Fisher Scientific filings provide 12 years of Other Working Capital Changes readings, the most recent being -$410.0 million for Q4 2020.

  • On a quarterly basis, Other Working Capital Changes fell 322.83% to -$410.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was -$1.5 billion, a 833.33% decrease, with the full-year FY2025 number at $1.3 billion, up 605.38% from a year prior.
  • Other Working Capital Changes hit -$410.0 million in Q4 2020 for Thermo Fisher Scientific, up from -$739.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $443.0 million in Q1 2020 to a low of -$746.0 million in Q2 2020.
  • Median Other Working Capital Changes over the past 5 years was $45.4 million (2016), compared with a mean of -$48.0 million.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 697.1% in 2017 and later plummeted 985.45% in 2019.
  • Thermo Fisher Scientific's Other Working Capital Changes stood at $60.7 million in 2016, then tumbled by 231.8% to -$80.0 million in 2017, then crashed by 146.25% to -$197.0 million in 2018, then skyrocketed by 193.4% to $184.0 million in 2019, then crashed by 322.83% to -$410.0 million in 2020.
  • The last three reported values for Other Working Capital Changes were -$410.0 million (Q4 2020), -$739.0 million (Q3 2020), and -$746.0 million (Q2 2020) per Business Quant data.